SARS, some things may have changed from the time this article was sent to the printer to when it appears in your mailbox. Thus, to keep abreast of the latest findings, including new diagnostic tests and treatment options, consult the CDC and WHO web sites regularly (TABLE 1) .
s SIGNS AND SYMPTOMS
SARS usually begins with fever, sometimes associated with chills or other symptoms, including headache, general feeling of discomfort, and body aches. After 2 to 7 days, patients may develop a dry, nonproductive cough.
The incubation period for SARS is typically 2 to 7 days; however, isolated reports have suggested an incubation period as long as 10 days. Note: Suspected cases with either radiographic evidence of pneumonia or acute respiratory distress syndrome or evidence of unexplained acute respiratory distress syndrome by autopsy are designated "probable" cases by the WHO case definition.
s SCREENING FOR SARS
To identify patients who may have SARS in ambulatory care settings, health care workers should ask targeted screening questions concerning fever, respiratory symptoms, and recent travel at triage or as soon as possible after patient arrival. The most recent case definition for SARS should be used as a basis for such screening questions.
Health care personnel who are the first points of contact should be trained for SARS screening. In the absence of systematic triage, providers caring for patients in ambulatory care settings should perform such screening before close contact.
Clinicians should evaluate persons meeting the case description and, if indicated, admit them to the hospital. Close contacts and health care workers should seek medical care for symptoms of respiratory illness.
s TRANSMISSIBILITY OF SARS
The principal way the SARS virus appears to be spread is through droplet transmission, ie, when someone sick with SARS coughs or sneezes droplets into the air and someone else breathes them in. Information to date suggests that people are most likely to be infectious when they have symptoms, such as fever or cough. However, it is not known how long before or after their symptoms begin that patients with SARS might be able to transmit the disease to others.
Cases of SARS continue to be reported primarily among people who have had direct, close contact with an infected person, such as those sharing a household with a SARS patient and health care workers who did not use infection control procedures while caring for a SARS patient. In the United States, there is no indication of community transmission at this time.
Most documented cases of transmission of SARS have occurred in either health care workers or household contacts of patients with SARS. In addition, other persons may be exposed to SARS, eg, international travelers from areas with community transmission or persons identified as a result of a public health investigation. Clinicians should save any available clinical specimens (respiratory, blood, and serum) for additional testing until a specific diagnosis is made.
s INFECTION CONTROL MEASURES
CDC staff are working to develop specific laboratory tests for SARS, such as serologic testing, indirect fluorescent antibody testing, enzyme-linked immunosorbent assays (ELISAs) that are specific for antibody produced after infection, and a reverse transcriptase-polymerase chain reaction (RT-PCR) test for the SARS virus.
Clinicians should regularly consult the www.cdc.gov web site for updated information on diagnostic testing.
s EMPIRIC THERAPY
Although the SARS virus has been identified and genetically sequenced, and corticosteroids and a variety of antiviral agents bave been tried, no specific treatment recommendation can be made at this time. Articles on SARS have recently been published on the web sites of the New England Journal of Medicine and The Lancet. The genetic sequence of the virus has been published on the CDC web site.
Empiric therapy should include coverage for organisms associated with any communityacquired pneumonia of unclear etiology, including agents with activity against both typical and atypical respiratory pathogens. Treatment choices may be influenced by severity of the illness. Infectious disease consultation is recommended.
s FOR POSSIBLE EXPOSURES
The following measures are recommended for persons other than health care workers or household contacts who may have been exposed to SARS. These recommendations are based on the experience in the United States to date and may be revised as more information becomes available:
• Persons who may have been exposed to SARS should be vigilant for fever or respiratory symptoms, and those who develop fever or respiratory symptoms should seek health care evaluation. When possible, before the evaluation, health care providers should be informed that the patient may have been exposed to SARS.
• Persons who may have been exposed to SARS and who develop fever or respiratory symptoms should limit their interactions outside the home and should not go to work, school, out-of-home child care, or other public areas until 10 days after the fever and respiratory symptoms resolve. During this time, infection control precautions at home should be used to minimize the potential for transmission.
• At this time, in the absence of fever or respiratory symptoms, persons who may have been exposed to SARS patients need not limit their activities outside the home and should not be excluded from school or work.
s TO REPORT SUSPECTED CASES OF SARS
Any clinician who identifies a suspected SARS case should collect information about the case and report it to the local or state health department. Information will be provided on the collection and transport of clinical samples through the state public health laboratory for analysis at the CDC.
